Learn More
Medchemexpress LLC BTX-A51 (casein kinase inhibitor A51) | 2079068-74-7 | MFCD34469352 | 98.6% | 360.88 | C18H25ClN6 | 100MG

Supplier: Medchemexpress LLC HY123954100MG
BTX-A51 is a potent, orally active inhibitor of casein kinase 1α (CK1α) used in preclinical research on leukemia and CK1α-related signaling pathways. It induces apoptosis in leukemia cell models and is supplied as a research-grade compound with characterized purity, formula, and molecular weight.
- Potent CK1α inhibition demonstrated in cellular assays.
- Induces apoptosis in leukemia cell models.
- Suitable for in vitro and in vivo preclinical studies.
- Characterized by confirmed molecular formula and molecular weight.
- Available in multiple milligram to gram quantities for research use.
- Provided with datasheet, certificate of analysis, and safety data sheet.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.